Volume 17, Number 2—February 2011
Letter
New Delhi Metallo-β-Lactamase, Ontario, Canada
Table
Antibacterial drug or gene |
MIC, μg/mL |
||
Kpn GN529 |
Eco J529 |
Eco J53 |
|
Ampicillin | >256 | >256 | 6 |
Cefoxitin | >256 | >256 | 8 |
Ceftazidime | >256 | >256 | 0.19 |
Cefotaxime | >256 | >256 | 0.094 |
Cefepime | 48 | 48 | 0.064 |
Ertapenem | 32 | 12 | 0.008 |
Meropenem | >32 | 4 | 0.023 |
Imipenem | >32 | 32 | 0.38 |
Amikacin | >256 | >256 | 1.5 |
Gentamicin | >256 | >256 | 1.5 |
Tobramycin | >256 | >256 | 1 |
Ciprofloxacin | >32 | 0.012 | 0.012 |
Tetracycline | >16 | 0.78 | 1 |
Tigecycline | 1 | ND | ND |
Nitrofurantoin | >512 | ND | ND |
Colistin | 0.5 | ND | ND |
Co-trimoxazole |
4/76 |
ND |
ND |
PCR† and sequencing | |||
blaNDM-1 | + | + | ND |
blaCTX-M-15 | + | − | ND |
blaSHV-12 | + | + | ND |
blaSHV-11 | + | – | ND |
blaOXA-1 | + | – | ND |
blaTEM-1 | + | – | ND |
armA | + | + | ND |
*Kpn, Klebsiella pneumoniae; Eco J529, Escherichia coli transconjugant strain; Eco J53, recipient E. coli J53; ND, not determined.
†PCR screening included blaTEM, blaSHV, blaOXA-1-like, blaCTX-M groups 1, 2, and 9, blaVEB, blaPER, blaGES, blaOXA-48-like, blaIMP, blaVIM, blaKPC, blaNDM-1, and 6 groups of blaAmpC genes.
Page created: July 13, 2011
Page updated: July 13, 2011
Page reviewed: July 13, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.